{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:53:18Z","timestamp":1793238798600,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.arcmed.2007.11.011","type":"journal-article","created":{"date-parts":[[2008,2,15]],"date-time":"2008-02-15T07:53:39Z","timestamp":1203062019000},"page":"265-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":190,"title":["Excitotoxic Neuronal Death and the Pathogenesis of Huntington's Disease"],"prefix":"10.1016","volume":"39","author":[{"given":"Ana Mar\u00eda","family":"Estrada S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Mej\u00eda-Toiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Massieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2007.11.011_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/306234a0","article-title":"A polymorphic DNA marker genetically linked to Huntington's disease","volume":"306","author":"Gusella","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2007.11.011_bib2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.arcmed.2007.11.011_bib3","unstructured":"Rasmussen A. Huntington infantil y juvenil. In: Mateos G\u00f3mez H, ed. Enfermedad de Huntington \u201cSeries del Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda Manuel Velasco Su\u00e1rez\u201d. M\u00e9xico, DF: 2000. pp. 22\u201327."},{"key":"10.1016\/j.arcmed.2007.11.011_bib4","series-title":"Huntington's Disease","author":"Harper","year":"1991"},{"key":"10.1016\/j.arcmed.2007.11.011_bib5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease","volume":"227","author":"Graveland","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2007.11.011_bib6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.arcmed.2007.11.011_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/263517a0","article-title":"Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids","volume":"263","author":"McGeer","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2007.11.011_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0024-3205(77)90384-8","article-title":"Neurochemical sequelae of kainate injections in corpus striatum and substantia nigra of the rat","volume":"20","author":"Schwarcz","year":"1977","journal-title":"Life Sci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0024-3205(84)90148-6","article-title":"Excitotoxic models for neurodegenerative disorders","volume":"35","author":"Schwarcz","year":"1984","journal-title":"Life Sci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02257483","article-title":"Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat","volume":"20","author":"Ambrose","year":"1994","journal-title":"Somat Cell Mol Genet"},{"key":"10.1016\/j.arcmed.2007.11.011_bib11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.arcmed.2007.11.011_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.arcmed.2007.11.011_bib14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","article-title":"Knock-in mouse models of Huntington's disease","volume":"2","author":"Menalled","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.arcmed.2007.11.011_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.arcmed.2007.11.011_bib16","first-page":"81","article-title":"Role of energy metabolism in neuronal death associated with cerebral ischemia and neurodegenerative diseases, and its prevention by energy substrates","author":"Massieu","year":"2003","journal-title":"Recent Res Dev Neurochem"},{"key":"10.1016\/j.arcmed.2007.11.011_bib17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jnr.1093","article-title":"Strategies for neuroprotection against L-trans-2,4-pyrrolidine dicarboxylate-induced neuronal damage during energy impairment in vitro","volume":"64","author":"Garc\u00eda","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.arcmed.2007.11.011_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1471-4159.1999.0720129.x","article-title":"Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired","volume":"72","author":"S\u00e1nchez-Carbente","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2007.11.011_bib19","series-title":"Basic Neurochemistry: Molecular, Cellular and Medical Aspects","first-page":"563","article-title":"Hypoxic-ischemic brain injury and oxidative stress","author":"Dugan","year":"2006"},{"key":"10.1016\/j.arcmed.2007.11.011_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/364535a0","article-title":"NMDA-dependent superoxide production and neurotoxicity","volume":"364","author":"Lafon-Cazal","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2007.11.011_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.arcmed.2007.11.011_bib22","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1073\/pnas.85.11.4079","article-title":"3-hydroxyanthranilate oxygenase activity is increased in the brains of Huntington's disease victims","volume":"85","author":"Schwarcz","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.11.011_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.expneurol.2005.07.004","article-title":"Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: implications for Huntington's disease","volume":"197","author":"Sapko","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.arcmed.2007.11.011_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0304-3940(00)00956-3","article-title":"Early kynurenergic impairment in Huntington's disease and in a transgenic animal model","volume":"14","author":"Guidetti","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.11.011_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0959-4388(00)00215-4","article-title":"NMDA receptor subunits: diversity, development and disease","volume":"11","author":"Cull-Candy","year":"2001","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.arcmed.2007.11.011_bib26","first-page":"577","article-title":"NMDA receptors in the basal ganglia","volume":"196","author":"Ravenscroft","year":"2000","journal-title":"J\u00a0Anat"},{"key":"10.1016\/j.arcmed.2007.11.011_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington's disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.arcmed.2007.11.011_bib28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.2841762","article-title":"NMDA receptor losses in putamen from patients with Huntington's disease","volume":"24","author":"Young","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2007.11.011_bib29","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJM199005033221807","article-title":"Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease","volume":"322","author":"Albin","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2007.11.011_bib30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00005072-199704000-00013","article-title":"Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease\u2014an in situ hybridization study","volume":"56","author":"Arzberger","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.arcmed.2007.11.011_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10048-004-0198-8","article-title":"NR2A and NR2B receptor gene variations modify age at onset in Huntington disease","volume":"6","author":"Arning","year":"2005","journal-title":"Neurogenetics"},{"key":"10.1016\/j.arcmed.2007.11.011_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00439-007-0393-4","article-title":"NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner","volume":"122","author":"Arning","year":"2007","journal-title":"Hum Genet"},{"key":"10.1016\/j.arcmed.2007.11.011_bib33","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.arcmed.2007.11.011_bib34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington disease","volume":"66","author":"Cepeda","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.arcmed.2007.11.011_bib35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nbd.2003.08.024","article-title":"Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation","volume":"14","author":"Luthi-Carter","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.arcmed.2007.11.011_bib36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000091921","article-title":"Changes in expression of N-methyl-D-aspartate receptor subunits occur early in the R6\/2 mouse model of Huntington's disease","volume":"28","author":"Ali","year":"2006","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib37","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.neurobiolaging.2003.04.003","article-title":"Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington's disease","volume":"24","author":"Li","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.arcmed.2007.11.011_bib38","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","article-title":"Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin","volume":"72","author":"Chen","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2007.11.011_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/mcne.2000.0909","article-title":"Mutant huntingtin enhances excitotoxic cell death","volume":"17","author":"Zeron","year":"2001","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jnr.20651","article-title":"Alteration in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6\/2 mouse model of Huntington's disease","volume":"82","author":"Starling","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.arcmed.2007.11.011_bib41","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.arcmed.2007.11.011_bib42","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.256.5060.1217","article-title":"Heteromeric NMDA receptors: molecular and functional distinction of subtypes","volume":"256","author":"Monyer","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2007.11.011_bib43","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.neuroscience.2007.03.010","article-title":"Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease","volume":"147","author":"Benn","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.arcmed.2007.11.011_bib44","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1523\/JNEUROSCI.4356-06.2007","article-title":"Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease","volume":"27","author":"Fan","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0896-6273(00)80590-5","article-title":"SAP90 binds and clusters kainate receptors causing incomplete desensitization","volume":"21","author":"Garcia","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.arcmed.2007.11.011_bib46","doi-asserted-by":"crossref","first-page":"24713","DOI":"10.1074\/jbc.M103501200","article-title":"Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95","volume":"276","author":"Sun","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2007.11.011_bib47","doi-asserted-by":"crossref","first-page":"33364","DOI":"10.1074\/jbc.M304240200","article-title":"Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-D-aspartate receptors","volume":"278","author":"Song","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2007.11.011_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-7091-0579-5_14","article-title":"The N-methyl-D-aspartate antagonist memantine retards progression of Huntington's disease","volume":"68","author":"Beister","year":"2004","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.arcmed.2007.11.011_bib49","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1007\/s100720200081","article-title":"Amantadine in Huntington's disease: open-label video-blinded study","volume":"23","author":"Lucetti","year":"2002","journal-title":"Neurol Sci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1212\/WNL.49.1.153","article-title":"Cognitive, behavioral, and motor effects of the NMDA antagonist ketamine in Huntington's disease","volume":"49","author":"Murman","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.11.011_bib51","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1212\/WNL.53.5.1000","article-title":"Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial","volume":"53","author":"Kremer","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.11.011_bib52","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1212\/01.WNL.0000096019.71649.2B","article-title":"Dosage effects of riluzole in Huntington's disease: a multicenter placebo-controlled study","volume":"61","author":"Huntington Study Group","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.11.011_bib53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mds.870110310","article-title":"A controlled trial of remacemide hydrochloride in Huntington's disease","volume":"11","author":"Kieburtz","year":"1996","journal-title":"Mov Disord"},{"key":"10.1016\/j.arcmed.2007.11.011_bib54","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1042\/CS20050148","article-title":"Pharmaceutical, cellular and genetic therapies for Huntington's disease","volume":"110","author":"Handley","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.arcmed.2007.11.011_bib55","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.11.011_bib56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.mcn.2003.11.014","article-title":"Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease","volume":"25","author":"Zeron","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib57","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/jnr.10100","article-title":"Immediate-early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice","volume":"67","author":"MacGibbon","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.arcmed.2007.11.011_bib58","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity","volume":"96","author":"Hansson","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.11.011_bib59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0361-9230(00)00238-0","article-title":"Mice transgenic for the human Huntington's disease mutation have reduced sensitivity to kainic acid toxicity","volume":"52","author":"Morton","year":"2000","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.arcmed.2007.11.011_bib60","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0306-4522(03)00382-8","article-title":"Neocortical neurons cultured from mice with expanded CAG repeats in the huntingtin gene: unaltered vulnerability to excitotoxins and other insults","volume":"120","author":"Snider","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.arcmed.2007.11.011_bib61","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1073\/pnas.94.8.3872","article-title":"Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease","volume":"94","author":"Rubinsztein","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.11.011_bib62","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.53.6.1330","article-title":"Evidence for the GluR6 gene associated with younger onset age of Huntington's disease","volume":"53","author":"MacDonald","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.11.011_bib63","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.11.011_bib64","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainres.2004.06.005","article-title":"The metabotropic glutamate receptor 5 antagonist MPEP and\u00a0mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease","volume":"1019","author":"Schiefer","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.arcmed.2007.11.011_bib65","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/j.1460-9568.2004.03633.x","article-title":"HAP1 facilitates effects of mutant huntingtin on inositol 1,4,5-trisphosphate-induced Ca release in primary culture of striatal medium spiny neurons","volume":"7","author":"Tang","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib66","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/exnr.2000.7542","article-title":"The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity","volume":"167","author":"Orlando","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1016\/j.arcmed.2007.11.011_bib67","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0028-3908(00)00079-4","article-title":"Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective","volume":"39","author":"Bruno","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arcmed.2007.11.011_bib68","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/nn1750","article-title":"Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport","volume":"9","author":"Custer","year":"2006","journal-title":"Nature Neurosci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib69","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0304-3940(86)90397-6","article-title":"Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease","volume":"67","author":"Cross","year":"1986","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.11.011_bib70","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.arcmed.2007.11.011_bib71","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington's disease transgenic mice","volume":"8","author":"Li\u00e9vens","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.arcmed.2007.11.011_bib72","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.arcmed.2007.11.011_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2004.05.008","article-title":"Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow","volume":"17","author":"Gianfriddo","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.arcmed.2007.11.011_bib74","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.0953-816X.2000.01379.x","article-title":"Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6\/1 Huntington transgenic mice","volume":"13","author":"Nicniocaill","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib75","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2007.11.011_bib76","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/hmg\/ddi067","article-title":"Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila","volume":"14","author":"Li\u00e9vens","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.arcmed.2007.11.011_bib77","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/exnr.2000.7481","article-title":"In vivo potentiation of glutamate-mediated neuronal damage after chronic administration of the glycolysis inhibitor iodoacetate","volume":"165","author":"Massieu","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.arcmed.2007.11.011_bib78","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.neuroscience.2007.03.024","article-title":"Exacerbation of excitotoxic neuronal death induced during mitochondrial inhibition in vivo: relation to energy imbalance","volume":"146","author":"Del R\u00edo","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.arcmed.2007.11.011_bib79","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(88)90765-2","article-title":"Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced","volume":"451","author":"Novelli","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.arcmed.2007.11.011_bib80","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0306-4522(97)00389-8","article-title":"3-Nitropropionic acid exacerbates N-methyl-D-aspartate toxicity in striatal culture by multiple mechanisms","volume":"84","author":"Greene","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.arcmed.2007.11.011_bib81","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(96)00600-8","article-title":"Ion homeostasis in brain cells: differences in intracellular ion responses to energy limitation between cultured neurons and glial cells","volume":"78","author":"Silver","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.arcmed.2007.11.011_bib82","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s11064-006-9189-5","article-title":"D-beta-hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition","volume":"31","author":"Mej\u00eda-Toiber","year":"2006","journal-title":"Neurochem Res"},{"key":"10.1016\/j.arcmed.2007.11.011_bib83","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.neuroscience.2006.12.069","article-title":"Sustained metabolic inhibition induces an increase in the content and phosphorylation of the NR2B subunit of N-methyl-D-aspartate receptors and a decrease in glutamate transport in the rat hippocampus in vivo","volume":"145","author":"Camacho","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.arcmed.2007.11.011_bib84","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410120504","article-title":"Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan","volume":"12","author":"Kuhl","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1016\/j.arcmed.2007.11.011_bib85","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/brain\/113.5.1405","article-title":"Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease","volume":"113","author":"Kuwert","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.arcmed.2007.11.011_bib86","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","article-title":"1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers","volume":"50","author":"Jenkins","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.11.011_bib87","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.arcmed.2007.11.011_bib88","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1073\/pnas.0609833104","article-title":"Selective defect of in vivo glycolysis in early Huntington's disease striatum","volume":"104","author":"Powers","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.11.011_bib89","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/archneur.55.10.1299","article-title":"Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders","volume":"55","author":"Kish","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.arcmed.2007.11.011_bib90","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1159\/000017344","article-title":"Glyceraldehyde 3-phosphate dehydrogenase abnormality in metabolically stressed Huntington disease fibroblasts","volume":"20","author":"Cooper","year":"1998","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib91","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nm0396-347","article-title":"Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH","volume":"2","author":"Burke","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.arcmed.2007.11.011_bib92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.arcmed.2007.11.011_bib93","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0022-510X(85)90112-1","article-title":"Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases","volume":"67","author":"Butterworth","year":"1985","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib94","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington's disease","volume":"29","author":"Browne","year":"2004","journal-title":"Neurochem Res"},{"key":"10.1016\/j.arcmed.2007.11.011_bib95","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib96","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.28.1.23","article-title":"Juvenile Huntington chorea: clinical, ultrastructural, and biochemical studies","volume":"28","author":"Goebel","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.11.011_bib97","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","article-title":"Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease","volume":"23","author":"Yu","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib98","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome C release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.arcmed.2007.11.011_bib99","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1101\/gad.1177604","article-title":"Transcriptional regulatory circuits controlling mitochondrial biogenesis and function","volume":"18","author":"Kelly","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.arcmed.2007.11.011_bib100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1\u03b1 by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.arcmed.2007.11.011_bib101","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1\u03b1 Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.arcmed.2007.11.011_bib102","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcription coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.arcmed.2007.11.011_bib103","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2006.10.023","article-title":"PGC-1\u03b1, a new therapeutic target in Huntington's disease?","volume":"127","author":"McGill","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.arcmed.2007.11.011_bib104","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.arcmed.2007.11.011_bib105","doi-asserted-by":"crossref","first-page":"30773","DOI":"10.1074\/jbc.M504749200","article-title":"Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin","volume":"280","author":"Milakovic","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2007.11.011_bib106","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1523\/JNEUROSCI.16-09-03019.1996","article-title":"Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease","volume":"16","author":"Palfi","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib107","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J Neurosci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib108","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbadis.2005.11.002","article-title":"Combination therapy using minocycline and coenzyme Q10 in R6\/2 transgenic Huntington's disease mice","volume":"1762","author":"Stack","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2007.11.011_bib109","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse model of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.arcmed.2007.11.011_bib110","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000090629.40891.4B","article-title":"Creatine supplementation in Huntington's disease: a placebo-controlled in pilot trial","volume":"61","author":"Verbessem","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.11.011_bib111","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.neuroscience.2006.05.043","article-title":"Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease","volume":"141","author":"Ryu","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.arcmed.2007.11.011_bib112","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.arcmed.2007.11.011_bib113","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/exnr.2002.7912","article-title":"Beta-amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and isolated nerve terminals: implications for Alzheimer disease","volume":"176","author":"Arias","year":"2002","journal-title":"Exp Neurol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440907004122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440907004122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:36:26Z","timestamp":1759260986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440907004122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":113,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0188440907004122"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2007.11.011","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excitotoxic Neuronal Death and the Pathogenesis of Huntington's Disease","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2007.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}